Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ:XETRA) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Eckert & Ziegler Strahlen- und Medizintechnik AG stock forecast from 0 analysts, the average analyst target price for Eckert & Ziegler Strahlen- und Medizintechnik AG is not available over the next 12 months. Eckert & Ziegler Strahlen- und Medizintechnik AG’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Eckert & Ziegler Strahlen- und Medizintechnik AG is Neutral, which is based on 7 positive signals and 7 negative signals. At the last closing, Eckert & Ziegler Strahlen- und Medizintechnik AG’s stock price was EUR 38.36. Eckert & Ziegler Strahlen- und Medizintechnik AG’s stock price has changed by +4.47% over the past week, +1.37% over the past month and -18.73% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for EUZ:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
